US Patent Issued to BEAM THERAPEUTICS on May 12 for "Compositions and methods for treating alpha-1 antitrypsin deficiency" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,931, issued on May 12, was assigned to BEAM THERAPEUTICS INC. (Cambridge, Mass.).

"Compositions and methods for treating alpha-1 antitrypsin deficiency" was invented by Nicole Gaudelli (Cambridge, Mass.), Michael Packer (Cambridge, Mass.), Bernd Zetsche (Cambridge, Mass.), Ian Slaymaker (Cambridge, Mass.), Yi Yu (Cambridge, Mass.), David A. Born (Cambridge, Mass.) and Seung-Joo Lee (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features compositions and methods for editing deleterious mutations associated with alpha-1 anti-trypsin (A1AT) deficiency. In particular embodiments, the invention provides methods for ...